pubmed-article:15184247 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0001430 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0032580 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0596290 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0538927 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C1516044 | lld:lifeskim |
pubmed-article:15184247 | lifeskim:mentions | umls-concept:C1637833 | lld:lifeskim |
pubmed-article:15184247 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:15184247 | pubmed:dateCreated | 2004-6-8 | lld:pubmed |
pubmed-article:15184247 | pubmed:abstractText | Celecoxib was shown to regress colorectal adenomas in familial adenomatous polyposis (FAP) patients relative to placebo. To address the mechanism of polyp regression, we determined whether celecoxib can modulate cell proliferation, apoptosis, and prostaglandin E(2) (PGE(2)) levels in colorectal epithelia from FAP trial participants and whether such alterations correlate with observed reductions in polyp number. | lld:pubmed |
pubmed-article:15184247 | pubmed:language | eng | lld:pubmed |
pubmed-article:15184247 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15184247 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15184247 | pubmed:month | Jun | lld:pubmed |
pubmed-article:15184247 | pubmed:issn | 1055-9965 | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:LevinBernardB | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:StephensL... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:SinicropeFran... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:MorrowJason... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:MorrisJeffrey... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:HalfElizabeth... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:LynchPatrick... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:HawkErnest... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:CohenDeborah... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:AyersGregory... | lld:pubmed |
pubmed-article:15184247 | pubmed:author | pubmed-author:Familial... | lld:pubmed |
pubmed-article:15184247 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15184247 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:15184247 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15184247 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15184247 | pubmed:pagination | 920-7 | lld:pubmed |
pubmed-article:15184247 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:meshHeading | pubmed-meshheading:15184247... | lld:pubmed |
pubmed-article:15184247 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15184247 | pubmed:articleTitle | Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. | lld:pubmed |
pubmed-article:15184247 | pubmed:affiliation | Department of Gastrointestinal Medicine and Nutrition, University of Texas M. D. Anderson Cancer Center, Houston, USA. sinicrope.frank@mayo.edu | lld:pubmed |
pubmed-article:15184247 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15184247 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15184247 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15184247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15184247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15184247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15184247 | lld:pubmed |